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2 
Abstract 26 
27 
Bacteriophages and bacteriocins are promising biocontrol tools in food. In this work, 28 
two Listeria bacteriophages, FWLLm1 and FWLLm3, were assessed in combination 29 
with the bacteriocin coagulin C23 to inhibit Listeria monocytogenes. Preliminary results 30 
under laboratory conditions demonstrated that both antimicrobials act synergistically 31 
when they were applied in suboptimal concentrations. The combined approach was 32 
further assessed in milk contaminated with 5 × 104 CFU/ml L. monocytogenes 2000/47 33 
and stored at 4ºC for 10 days. When used alone, phage FWLLm1 added at 5 × 10634 
PFU/ml, FWLLm3 at 5 × 105 PFU/ml and coagulin C23 at 584 AU/ml kept L. 35 
monocytogenes 2000/47 counts lower than the untreated control throughout storage. 36 
However, when used in combination, inhibition was enhanced and in the presence of 37 
FWLLm1 and coagulin C23, L. monocytogenes 2000/47 counts were under the 38 
detection limits (less than 10 CFU/ml) from day 4 until the end of the experiment. 39 
Resistant mutants towards phages and coagulin C23 could be obtained, but cross-40 
resistance was not detected. Mutants resistant to FWLLm3 and coagulin C23 were also 41 
recovered from surviving colonies after cold storage in milk which may explain the 42 
failure of this combination to inhibit L. monocytogenes. Remarkably, the fraction of 43 
resistant mutants isolated from the combined treatment was lower than that from each 44 
antimicrobial alone, suggesting that synergy between bacteriocins and phages could be 45 
due to a lower rate of resistance development and the absence of cross-resistance. 46 
47 
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3 
Highlights 52 
 The combined used of bacteriocins and bacteriophages synergistically inhibits 53 
Listeria monocytogenes in broth 54 
 Both antimicrobials enhanced safety of milk under cold storage 55 
 Synergy could be linked to a lower frequency of development of resistant 56 
mutants to each antimicrobial 57 
 Cross-resistance was not detected 58 
59 
60 
4 
1. INTRODUCTION 61 
62 
Listeria monocytogenes is the causative agent of listeriosis, a foodborne disease 63 
which affects the elderly, pregnant women, unborn and newborn babies and people with 64 
weakened immune systems (Allerberger and Wagner, 2010). In healthy adults and 65 
children, listeriosis causes few or no symptoms and may be mistaken for a mild viral 66 
infection or flu which makes the incidence of listeriosis difficult to establish (Bortolussi, 67 
2008). However, an increasing rate of this foodborne illness has been reported in 68 
Europe in recent years related to a higher rate of listeriosis in people ³ 65 years of age 69 
(Goulet et al., 2008). 70 
L. monocytogenes is a serious concern for the food industry as this pathogen can 71 
grow at refrigeration temperatures commonly used to control pathogens in foods (4ºC to 72 
10ºC) and tolerates high concentrations of salt and low pH (Ferreira et al., 2014). Many 73 
categories of food have been related with listeriosis outbreaks: milk, soft cheeses and 74 
other dairy products, sausages, smoked fish, salads, delicatessen and ready-to-eat 75 
products (Garrido et al., 2010). The majority of detected outbreaks have been caused by 76 
ready-to-eat meats and cheeses (Cartwright et al., 2013; Garrido et al., 2010). Although 77 
L. monocytogenes is inactivated by thermal treatments used in processed food, post-78 
processing cross-contamination from equipment and environment may occur due to the 79 
persistence of this pathogen in processing plants (Ferreira et al., 2014; Meloni et al., 80 
2014; Ortiz et al., 2014) as a result of the development of resistance to disinfectants and 81 
its ability to form biofilms (Ferreira et al., 2014). 82 
Listeriaphages have been proposed as new tools for Listeria biocontrol. 83 
Bacteriophages or phages, the natural killers of bacteria, are widely distributed in all 84 
environments, including food, and are presumed safe for humans, animals and plants. 85 
They have been successfully assessed as new tools to reduce levels of foodborne 86 
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pathogens and spoilage bacteria along the food chain. Listeria phages have been 87 
isolated from several environments (sewage plants, silage, food processing 88 
environments, lysogenic strains) and used for detection of L. monocytogenes in food as 89 
well as for reducing its presence in food processing equipment and on ready-to-eat 90 
products (García et al., 2010; Hagens and Loessner, 2014). 91 
Another strategy to ensure food safety is the use of bacteriocins as natural 92 
biopreservatives. Bacteriocins are ribosomally synthesized antimicrobial peptides or 93 
proteins with bactericidal or bacteriostatic activity produced by bacteria (Drider and 94 
Rebuffat, 2011). These antimicrobial peptides have been traditionally used as 95 
biopreservatives to extend the shelf life of food products without compromising their 96 
nutritional and organoleptic properties (Gálvez et al., 2010; García et al., 2010). In this 97 
context, bacteriocins are regarded as an additional barrier to inhibit growth of 98 
undesirable microorganisms (Omar et al., 2013) and have already been successfully 99 
applied in several food systems to control the growth of L. monocytogenes (Davies et 100 
al., 1997; Franklin et al., 2004; Wan et al., 1997). 101 
In this work, two Listeria phages, FWLLm1 and FWLLm3, and one bacteriocin, 102 
coagulin C23, were used in combination looking for a synergistic effect to reduce or 103 
eliminate the presence of L. monocytogenes in milk. Coagulin C23 is produced by 104 
Lactobacillus paraplantarum IPLA C23 and has been reported to have antimicrobial 105 
activity against L. monocytogenes (Allende et al., 2007; Rilla-Villar, 2003). Coagulin 106 
C23 is identical to coagulin A, a natural variant of the class IIa bacteriocin pediocin 107 
PA1/AcH (Hyronimus et al., 1998). FWLLm1 and FWLLm3 are myoviruses isolated 108 
from sheep faeces that infect strains of the species L. monocytogenes as well as other 109 
species such as Listeria ivanovii and Listeria welshimeri (Bigot et al., 2011; Arachchi et 110 
al., 2013). FWLLm1 was reported to immediately reduce 2.5 log10 CFU/cm2 a L. 111 
monocytogenes contamination after addition on the surface of vacuum-packed ready-to-112 
6 
eat chicken breast roll (Bigot et al., 2011) suggesting its potential for biocontrol of this 113 
pathogen in food. 114 
115 
2. MATERIAL AND METHODS 116 
117 
2.1 Bacteria, phages, bacteriocin and growth conditions 118 
L. monocytogenes 2000/47 strain, which is a subtype that has caused listeriosis 119 
sporadic cases and outbreaks in New Zealand for several years (Sim et al., 2002), was 120 
used to contaminate milk samples and as host of phages for propagation. Listeria cells 121 
were grown at 32ºC under static conditions or at 37°C with shaking in TSB (Triptone 122 
Soy Broth, Scharlau, Barcelona, Spain) or TSB supplemented with 2% (w/v) 123 
bacteriological agar (TSA). Phage FWLLm1 and FWLLm3 preparations were obtained 124 
from 10 ml of L. monocytogenes 2000/47 which was infected with the phages at a ratio 125 
1:1 (phage:bacteria). The infected cultures were then incubated for 3 h at 37ºC with 126 
shaking. Concentrated coagulin C23 supernatants were obtained from L. paraplantarum127 
IPLA C23 cultures grown overnight at 32ºC in MRS broth (Scharlau, Spain). Ninety ml 128 
of the supernatant were mixed with 10 ml trichloroacetic acid 100% and incubated 1 h 129 
at 4ºC. After centrifugation, the supernatant was discarded and the dried pellet was 130 
resuspended in 5 ml sodium phosphate buffer 50 mM pH 6.8 by shaking at room 131 
temperature. The insoluble fraction was removed by centrifugation and the supernatant 132 
was adjusted to pH 5.5-6.5 with NaOH and filter sterilized. Bacteriocin activity was 133 
quantified by the agar diffusion test using 20 l of 2-fold dilutions placed in wells made 134 
on L. monocytogenes 2000/47 indicator plates. Arbitrary units (AU) were defined as the 135 
inverse of the last dilution that gave a clear halo and expressed by ml. Coagulin C23 136 
samples routinely contained 12,800 AU/ml. 137 
138 
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2.2 Challenge test in liquid medium 139 
Two ml TSB were inoculated with a colony of L. monocytogenes 2000/47 and 140 
incubated overnight at 32ºC. Then, 10 ml TSB were inoculated at 1% with the overnight 141 
culture and grown to an optical density OD600nm of 0.1 followed by a 1/10 dilution to 142 
obtain 5 × 106 CFU/ml. The culture was divided into 2 ml aliquots, each aliquot was 143 
mixed with 1 ml of TSB containing 10 mM Ca(NO3)2, 10 mM MgSO4 and the following 144 
volumes of FWLLm1 (36 µl), FWLLm3 (820 µl), coagulin C23 (137 µl), respectively, 145 
or a mix of phage and bacteriocin to get a final 1:10 phage:bacteria ratio and coagulin 146 
C23 at 584 AU/ml final concentration. Samples were incubated at 32ºC and viable 147 
counts were monitored every 2 h on TSA for a period of 6 h by serial dilutions of the 148 
samples. 149 
150 
2.3 Challenge test in milk under refrigeration conditions 151 
Ten ml of Extended Shelf Life milk (ESL) were inoculated with approximately 5 152 
× 104 CFU/ml of L. monocytogenes 2000/47 grown to OD600nm = 0.1. Aliquots (2 ml) 153 
were mixed with ESL milk (final volume of 1 ml) containing 10 mM Ca(NO3)2, 10 mM 154 
MgSO4 and the following volumes of FWLLm1(12.5 µl), FWLLm3 (25 µl), coagulin 155 
C23 (137 µl) or a mix of phage and bacteriocin. FWLLm3 was added at ratio 156 
phage:bacteria 10:1, FWLLm1 at 100:1 and coagulin C23 at 584 AU/ml final 157 
concentration. Samples were incubated a 4ºC for 10 days. Viable counts were checked 158 
every 24 h on TSA. 159 
160 
2.4 Resistance development to coagulin C23 and listeriaphages 161 
Drops (10 µl) of coagulin C23 were placed onto a L. monocytogenes 2000/47 162 
lawn and incubated 48 h at 32ºC. Putative coagulin C23 resistant colonies were picked 163 
from the inhibition halos, grown overnight in TSB and tested against coagulin C23 164 
8 
using the agar diffusion test. L. monocytogenes resistant cells were grown for 5 165 
additional overnight cultures in TSB in the absence of selective pressure to allow any 166 
putative phenotype-reversion of non-genetically altered strains. Then, cultures were 167 
tested again against coagulin C23. Cross-resistance to phages was tested by dropping 168 
phages FWLLm1 and FWLLm3 (5 µl) onto lawns of the C23-resistant cultures.  169 
Bacteriophage-insensitive mutants (BIMs) were also obtained from L. 170 
monocytogenes 2000/47 using phage FWLLm3. One-hundred µl of a 1:10 diluted 171 
overnight culture of L. monocytogenes 2000/47 (107 CFU) were incubated with 100 µl 172 
of phage (108 PFU) for 10 min at 37ºC. Then, the mixture was poured onto a TSA plate 173 
and covered with 3 ml of 0.7% TSA. Plates were incubated during 16 h at 37ºC. Ten 174 
surviving colonies were picked up and grown in fresh TSB for 16 h at 37ºC. 175 
Bacteriophage susceptibility was tested by the drop assay. Cross-resistance 176 
development was tested by dropping coagulin C23 onto the lawns obtained from the 177 
surviving colonies. 178 
179 
3. RESULTS  180 
181 
3.1 Coagulin C23 and the listeriaphages FWLLm1 and FWLLm3 act 182 
synergistically to kill L. monocytogenes in broth. 183 
The potential synergistic effect of coagulin C23 and listeriaphages was assessed 184 
in broth at 37ºC (Fig. 1). Combination of coagulin C23 and phage FWLLm1 decreased 185 
the concentration of L. monocytogenes 2000/47 by 5.9 log units after 2 h of incubation 186 
compared to the untreated control, while 3 and 4.8 log reductions were caused by 187 
FWLLm1 and C23 alone, respectively (Fig. 1A). After two hours of incubation, re-188 
growth was observed in all samples. On the contrary, when coagulin C23 was combined 189 
with FWLLm3, L. monocytogenes 2000/47 was under detection limits after 2 h and no 190 
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re-growth occurred. FWLLm3 and C23 alone were able to reduce the initial 191 
contamination by 4 and 4.4 log units, respectively (Fig. 1B) but growth resumed 192 
afterwards.  193 
194 
3.2. Coagulin C23 and listeriaphages FWLLm1 and FWLLm3 act synergistically 195 
to kill L. monocytogenes in milk under storage conditions. 196 
The synergistic effect between listeriaphages and coagulin C23 was further 197 
confirmed in milk inoculated with 104 CFU/ml of L. monocytogenes 2000/47 at 4ºC for 198 
10 days of storage (Fig. 2). In the control cultures the Listeria strain steadily multiplied 199 
up to 108 CFU/ml at the end of the experiment. Phage FWLLm1 progressively reduced 200 
viable counts, reaching 102 CFU/ml (6 log units reduction) after 8 days of incubation. At 201 
day 10 an increase of 1 log unit was observed (Fig. 2A). Phage FWLLm3 was able to 202 
restrict the concentration to approximately 104 CFU/ml (4 log units reduction) until day 203 
8, reaching 106 CFU/ml at the end of the experiment (Fig. 2B). When coagulin C23 was 204 
used alone, a progressive reduction could be also observed reaching 102 CFU/ml in the 205 
middle of the incubation period followed by re-growth. When phage FWLLm1 and 206 
coagulin C23 were used in combination, a complete reduction of the viable counts 207 
under the detection limits after 2 days of incubation at 4ºC and until the end of the 208 
assessed period was observed (Fig. 2A). On the contrary, combination of FWLLm3 and 209 
C23 led to a cell count reduction of 7.5 log units in day 4 followed by a 1.7 log units 210 
increase at the end of the experiment (Fig. 2B).  211 
212 
3.3 Assessment of resistance development towards coagulin C23 and listeriaphage 213 
after antimicrobial challenges 214 
L. monocytogenes 2000/47 was exposed to the antimicrobials (coagulin C23 and 215 
FWLLm3) individually and the resistant phenotypes of surviving colonies were 216 
10 
examined. Six resistant colonies were obtained from the inhibition halo produced by 217 
coagulin C23 onto a L. monocytogenes 2000/47 lawn. All these colonies were resistant 218 
to the bacteriocin as judged by the absence of inhibition halos by the agar spot test (data 219 
not shown). Furthermore, these mutants remained resistant to coagulin C23 after 5 days 220 
of consecutive culturing in broth without the bacteriocin, suggesting that the resistant 221 
phenotype was fairly stable. Likewise, five bacteriophage-insensitive mutants were also 222 
obtained from a plate containing L. monocytogenes 2000/47 and FWLLm3. Cross-223 
resistance was assessed using both coagulin C23 and FWLLm3 resistant cells. All 224 
bacteriocin resistant cells were sensitive to FWLLm3 and all BIMs were sensitive to 225 
coagulin C23 (data not shown). Therefore, no cross-resistance was observed. 226 
 To determine if the bacterial re-growth observed in milk challenges could be due 227 
to the selection of resistant variants, resistance development was also assessed at the 228 
end of the incubation period (10 days) in those samples where re-growth was observed. 229 
Ten surviving colonies from FWLLm1, FWLLm3, C23 and FWLLm3+C23 counting 230 
plates were cultured in TSB to prepare lawns and drops of the corresponding 231 
antimicrobial were spotted. In case of colonies isolated from FWLLm1 plates, all of 232 
them were sensitive to this phage (Table 1) while half of the colonies isolated from 233 
FWLLm3 plates were phage-resistant. Similarly, 55% of the colonies isolated from C23 234 
plates were resistant to the bacteriocin. When FWLLm3 was used in combination with 235 
C23, all the colonies were sensitive to the phage and only 40% were resistant to C23 236 
(Table 1). 237 
238 
4. DISCUSSION 239 
240 
The potential of phages as biocontrol agents in food is supported by several studies that 241 
indicate an efficient reduction of pathogens levels in meat, fresh fruits, vegetables and 242 
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processed foods (Endersen et al., 2014). For reducing L. monocytogenes contamination 243 
in food, there are already commercially available phage preparations against L. 244 
monocytogenes, which have been approved by the US FDA as processing-aids (U.S. 245 
FDA/CFSAN, 2007). On the other hand, the use of bacteriocins in food safety has been 246 
addressed along the whole production chain, as well as their use as food 247 
biopreservatives; authorized bacteriocin-containing products, including nisin and 248 
pediocin PA1/AcH, are also marketed (Gálvez et al., 2010; Omar et al., 2013). Starter 249 
and non-starter bacteriocin-producing strains have been successfully used to control L. 250 
monocytogenes in fresh cheese (Coelho et al., 2014; Vera Pingitore et al., 2012). As 251 
with any other potential food additive or processing aid, safety studies must be 252 
conducted on a case-by case basis according to regulations in force in each country. 253 
Moreover, the use of food biopreservatives must also be cost-effective. One way to 254 
lower the effective concentrations without compromising activity is to use the 255 
synergistic effects that are often observed between two antimicrobial agents that feature 256 
different mechanisms of action or attack different targets. For example, combination of 257 
nisin and polymyxin B allows a considerable reduction in the amount of nisin needed 258 
for the effective inhibition of Listeria spp. (Naghmouchi et al., 2010).  259 
In this work, we have assessed the combinations of two lytic listeriaphages and 260 
an anti-Listeria bacteriocin to reduce or eliminate this foodborne pathogen under 261 
laboratory conditions, i.e. optimal growth conditions, and in milk under refrigeration 262 
conditions. Phages FWLLm1 and FWLLm3, and coagulin C23 alone were able to 263 
reduce the amount of L. monocytogenes cells compared with the untreated control in 264 
both broth at 37ºC and milk at 4ºC. However, the combination resulted in a higher 265 
reduction or complete elimination of the viable counts, which suggests a synergistic 266 
effect between the listeriaphages and coagulin C23. Enhanced killing activity by 267 
combining phages and the bacteriocin nisin has been reported against L. monocytogenes268 
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in artificially contaminated fresh-cut melons and apples (Leverentz et al., 2003) and 269 
against S. aureus in pasteurized milk (Martínez et al., 2008), supporting the potency of 270 
this approach in food biopreservation.271 
When keeping the same phage to bacteria ratio in vitro, the combination 272 
FWLLm3+C23 was more effective than FWLLm1+C23 in eliminating L. 273 
monocytogenes since re-growth was observed with the latter, while FWLLm3+C23 274 
viable counts were under the detection limits after 2 h and onwards. Therefore, in order 275 
to improve the lytic ability of phage FWLLm1, challenge assays in milk were 276 
performed using a 100:1 phage:bacteria ratio. In these conditions, FWLLm1+C23 277 
effectively inhibited L. monocytogenes while surviving cells were recovered in samples 278 
treated with FWLLm3+C23. Failure to completely inhibit bacterial growth has been 279 
reported in phage-treated solid food, which has been explained by the immobilization of 280 
the phage particles on the food surfaces and matrix, and their inability to reach the 281 
bacterial targets (Chibeu et al., 2013; Guenther et al., 2012; Guenther et al., 2009; 282 
Guenther and Loessner, 2011). Even when FWLLm1 was used to control L. 283 
monocytogenes in RTE chicken breast roll at 30ºC, re-growth was observed after 5 h of 284 
incubation (Bigot et al., 2011). Milk may also present barriers to phage and bacteriocin 285 
biocontrol. For example, milk proteins or fat globules may hamper contact between 286 
phages and their target cells, resulting in inactivation of the phages (García et al., 2009; 287 
O'Flaherty et al., 2005). In addition, the negative effect of milk fat on the antimicrobial 288 
potency of bacteriocins, caused by adsorption of these hydrophobic molecules onto fat 289 
globules has also been reported (Sobrino-López and Martín-Belloso, 2008). 290 
Another reason which may explain failure of bacteriocins and phages to inhibit 291 
pathogen growth is the development of resistance (García et al., 2010). Bacterial 292 
resistance to phage may be due to a number of mechanisms, including absence or 293 
masking of phage receptors, prevention of injection of the phage genome into the host 294 
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cells, immunity to superinfection, and restriction-modification (RM) systems that 295 
degrade phage DNA while the host DNA is protected by methylation (Hyman and 296 
Abedon, 2010). Recently, a novel type of CRISPR system of phage resistance has been 297 
described in L. monocytogenes (Sesto et al., 2014). The development of resistance 298 
towards pediocin-like bacteriocins such as coagulin C23 is typically caused by a 299 
decreased expression of the mannose phosphotransferase system and by an altered cell 300 
surface (Drider et al., 2006; Kjos et al., 2011; Vadyvaloo et al., 2004). In L. 301 
monocytogenes, exposure to sublethal concentrations of pediocin (Laursen et al., 2014) 302 
or environmental stresses (Bergholz et al., 2013) promotes an adaptive response that 303 
facilitates resistance development. 304 
In this context, we explore resistance towards coagulin C23 and the 305 
listeriaphages within the surviving colonies in our experiments as well as the risk of 306 
cross-resistance. In the milk challenge with the phages alone, phage resistance was only 307 
detected against FWLLm3 where 50% of the tested colonies were phage-insensitive 308 
(Table 1). Thus, failure of inhibiting L. monocytogenes could be also explained by 309 
interference with the food matrix and the inability of the phage to reach its target. On 310 
the other hand, and in line with previous reports (Drider et al., 2006; Kjos et al., 2011), 311 
resistant mutants to coagulin C23 were frequently isolated which would preclude the 312 
use of this bacteriocin alone. Remarkably, the fraction of resistant mutants was lower 313 
when the bacteriocin was combined with FWLLm3. Likewise, surviving colonies from 314 
the combined FWLLm3+C23 treatment were all phage sensitive in contrast to the 315 
higher frequency of phage resistant mutants when the phage was used alone. These 316 
results support the notion that synergy between phages and bacteriocins could be 317 
explained by a lower rate of resistance development. Nevertheless, further research is 318 
needed to decipher the mechanisms involved.  319 
14 
No cross-resistance was observed between coagulin C23 and the listeriaphages. 320 
Phage-insensitive cells were sensitive to coagulin C23 and coagulin C23 resistant cells 321 
were sensitive to listeriaphages, which further ensures the efficacy of the combination. 322 
It seems that access to phage receptors was not hindered by the cell envelope changes 323 
involved in resistance to coagulin C23. Previous results for S. aureus showed that nisin-324 
adapted cells seriously compromised bacteriophage activity (Martinez et al., 2008). 325 
Similarly, resistant-mutants to the bacteriocin lactococin 972 were not infected by lytic 326 
phage c2 (Roces et al., 2012). 327 
Overall, we have demonstrated that the combination of listeriaphages and the 328 
bacteriocin coagulin C23 is more effective as a biopreservative in milk against L. 329 
monocytogenes under refrigeration conditions than each antimicrobial alone, and thus it 330 
could be a smart strategy to ensure milk safety during storage conditions.  331 
332 
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7. TABLES 478 
479 
Table 1. Percentage of sensitive/resistant colonies isolated from milk samples treated 480 
with each antimicrobial (n=10). 481 
482 
Antimicrobial Sensitive (%) Resistant (%) 
FWLLm1 100 - 
FWLLm3 50 50 
Coagulin C23 45 55 
FWLLm3+C23 60 (to C23) 40 
100 (to FWLLm3) - 
483 
484 
8. FIGURES 485 
486 
Figure 1. Killing of L. monocytogenes 2000/47 at 37ºC in broth. Samples were 487 
inoculated with 5 × 106 CFU/ml of L. monocytogenes 2000/47 and incubated for 6 h at 488 
37ºC without antimicrobials (control; ¨) or in the presence of A) bacteriophage 489 
FWLLm1 (5 x 105 PFU/ml) (), coagulin C23 (584 AU/ml) (), combination 490 
FWLLm1+C23 (); B) bacteriophage FWLLm3 (5 x 105 PFU/ml) (), coagulin C23 491 
(584 AU/ml) (), combination FWLLm3+C23 (). Values are the means of two 492 
independent experiments with standard deviation indicated by vertical bars. 493 
494 
Figure 2. Killing of L. monocytogenes 2000/47 at 4ºC in Extended Shelf Life (ESL) 495 
milk. Samples were inoculated with 5 × 104 CFU/ml of L. monocytogenes 2000/47 and 496 
incubated for 10 days at 4ºC without antimicrobials (control; black bars) or in the 497 
22 
presence of A) bacteriophage FWLLm1 (5 x 106 PFU/ml) (light grey bars), coagulin 498 
C23 (584 AU/ml) (white bars), combination FWLLm1+C23 (dark grey bars); B) 499 
bacteriophage FWLLm3 (5 x 105 PFU/ml) (light grey bars), coagulin C23 (584 AU/ml) 500 
(white bars), combination FWLLm3+C23 (dark grey bars). Values are the means of two 501 
independent experiments with standard deviation indicated by vertical bars. 502 
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